Acuplus Advanced Therapy for Pain and Recovery

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with sore muscles and joints. Specifically, it is effective for conditions such as arthritis, simple backache, strains, bruises, and sprains.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should apply the medication to the affected area no more than three to four times daily. For children under 2 years of age, it is recommended to consult a physician prior to use.

The medication should be stored at room temperature to maintain its efficacy.

Contraindications

The product is contraindicated in the following situations:

Application to wounds or damaged skin is prohibited due to the potential for adverse reactions. The use of this product in conjunction with other ointments, creams, sprays, or liniments is not recommended, as it may lead to unpredictable interactions. It should not be applied to irritated skin or if excessive irritation develops, as this may exacerbate the condition. Bandaging the area after application is contraindicated, as it may increase the risk of irritation or other complications. Additionally, the use of heating pads or devices in conjunction with this product is not advised due to the potential for increased skin sensitivity or burns.

This product is for external use only and should be kept away from excessive heat or flame. Hands should be washed with cool water after use. If the condition worsens or symptoms persist for more than 7 days, discontinue use and consult a healthcare professional. Contact with the eyes or mucous membranes should be avoided to prevent irritation.

Warnings and Precautions

Use of this product should be strictly in accordance with the provided directions to ensure safety and efficacy.

For external use only, this product must be kept away from excessive heat or open flame to prevent any potential hazards. It is imperative to avoid contact with the eyes or mucous membranes, as this may lead to irritation or adverse reactions.

In the event that the condition worsens or if symptoms persist beyond a duration of 7 days, it is essential to discontinue use and consult a healthcare professional for further evaluation and guidance.

Side Effects

Patients should be aware of the following adverse reactions associated with the use of this product. It is essential to use the product only as directed to minimize risks.

In clinical settings, participants have reported that the product is for external use only and should be kept away from excessive heat or flame. Care should be taken to avoid contact with the eyes or mucous membranes during application. The product should not be applied to wounds or damaged skin, nor should it be used in conjunction with other ointments, creams, sprays, or liniments. Additionally, it is advised not to apply the product to irritated skin or if excessive irritation develops. Bandaging the area after application is not recommended, and the use of heating pads or devices in conjunction with the product should be avoided.

Patients are instructed to wash their hands with cool water after use to prevent unintended contact with sensitive areas. If the condition worsens or if symptoms persist for more than 7 days, patients should discontinue use and consult a healthcare professional.

It is crucial to keep this product out of reach of children to prevent accidental ingestion or misuse.

Drug Interactions

Co-administration of this medication with other topical formulations, such as ointments, creams, sprays, or liniments, is contraindicated. The use of heating pads or devices in conjunction with this medication is also not recommended, as it may lead to adverse effects.

There are no specific interactions identified with laboratory tests associated with this medication. Therefore, routine monitoring of laboratory parameters is not necessary in the context of drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Acuplus Advanced Therapy for Pain and Recovery (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a physician prior to use. For children aged 2 years and older, the recommended application is to the affected area not more than three to four times daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of AcuPlus Advanced Therapy for Pain and Recovery (menthol solution) during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use during this period. Healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as there is no available data to guide dosing or monitoring in this population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide valuable assistance in managing potential overdosage cases.

Continued vigilance and adherence to dosing recommendations are crucial to minimize the risk of overdosage and ensure patient safety.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the product is intended for external use only and must be kept away from excessive heat or flame. Patients should be instructed not to apply the product to wounds or damaged skin, and to avoid using it in conjunction with other ointments, creams, sprays, or liniments.

It is important for healthcare providers to inform patients not to apply the product to irritated skin or if excessive irritation develops. Patients should also be cautioned against bandaging the area after application and should refrain from using the product with heating pads or devices.

Healthcare providers should emphasize the importance of washing hands with cool water after using the product. Patients should be advised to seek medical attention if their condition worsens or if symptoms persist for more than 7 days. Additionally, patients should be warned to avoid contact with the eyes or mucous membranes to prevent adverse effects.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is kept away from excessive heat or open flame to maintain its integrity.

After each use, it is recommended to wash hands with cool water to ensure proper hygiene. Additionally, the product should be discarded after opening to prevent any potential contamination or degradation.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of three to four times daily for adults and children aged 2 years and older. For children under 2 years of age, it is advised to consult a physician prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Acuplus Advanced Therapy for Pain and Recovery, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)